Marta Román - Concepedia

Author

Marta Román

Centro de Investigación Biomédica en Red de Cáncer ORCID

Also Known As

M. Román, M. Zambrano Roman, Mar Garrido Román, Marta Roman, Marta Román

Publications

537

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación Biomédica en Red de Cáncer Universidad de Navarra Navarre Institute of Health Research Stanford University Clinica Universidad de Navarra

About

Marta Román is an author at Centro de Investigación Biomédica en Red de Cáncer specializing in medicine, tumor biology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	104
2	Cell Biology	2	2	88
3	Allergy	1	1	16
4	Endocrinology	1	1	16
5	Cancer Cell Biology	1	1	38

Marta Román

Publications

219

Citations

H-Index

Page 1

	Year	Citations
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas Karmele Valencia, Oihane Erice, Kaja Kostyrko, Journal of Clinical Investigation Cancer ResearchResident MirnasTumor MicroenvironmentCancer GenomicsKras-driven Oncogenesis	2019	50
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche Eduardo Castañón, Alex Soltermann, Inés López, Cancer Letters Pre-metastatic NicheMedicineEmt ProgramCancer Cell BiologyEpithelial-mesenchymal Interactions	2017	38
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma Kaja Kostyrko, Marta Román, Alex G. Lee, Nature Communications	2023	38
Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i> -Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network Marta Román, Inés López, Elizabeth Guruceaga, Cancer Research	2018	37
Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells Iosune Baraibar, Marta Román, María Rodríguez‐Remírez, Cancers	2020	20
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer Irati Macaya, Marta Román, Connor Welch, Nature Communications	2023	20
Endocrine Disruptors: Time to Act Mariana F. Fernández, Marta Román, Juan Pedro Arrebola, Current Environmental Health Reports Endocrine DisruptorsAllergyEndocrine MechanismToxicologyEndocrinology	2014	16

Page 1